Lead citrate
CAS No. 512-26-5
Lead citrate( —— )
Catalog No. M37961 CAS No. 512-26-5
Lead citrate
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 22 | In Stock |
|
| 10MG | 38 | In Stock |
|
| 25MG | 56 | In Stock |
|
| 50MG | 98 | In Stock |
|
| 100MG | 128 | In Stock |
|
| 200MG | 168 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLead citrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionLead citrate
-
DescriptionLead citrate
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number512-26-5
-
Formula Weight999.8
-
Molecular FormulaC12H10O14Pb3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
EC5026
EC5026 has the potential to relieve pain by stabilizing natural analgesic and anti-inflammatory mediators.?EC5026 (BPN-19186) is a first-in-class, small molecule that potently inhibits soluble Epoxide Hydrolase (sEH), a key regulatory enzyme involved in the metabolism of membrane fatty acids.?Inhibition of sEH treats pain by stabilizing natural analgesic and anti-inflammatory mediators.
-
TNF-α (46-65), human
Human TNF alpha (46-65) peptide.
-
TriacetonaMine
Triacetonamine protects the activitis of superoxide dismutase(SOD) and creatine phos-phate kinase (CPK); it also inhibits CaCl2 induced agglomeration of thromocyte. Triacetonamine can improve the constructile function of heart mus-cles of acute anemia and decrease the content of malodialdehyde (MDA) in the heart muscles.
Cart
sales@molnova.com